Marinella Messina

Clinical Program Director at Race Oncology

Dr Marinella Messina is highly experienced oncology clinical trials specialist, having managed a wide range of clinical trials over the past 10 years, across all development phases (1, II, III and IV).

Dr Messina has worked with bio pharmaceutical companies and academic research investigators during this time, including Noxopharm where she was Clinical Operations Manager and Clinical Program Manager for their lead anti-cancer drug candidate Veyonda®.

Prior to this, Dr Messina was a Senior Clinical Project Manager at Datapharm, an Australian Clinical Research Organisation (CRO), where she oversaw the start-up, recruitment and management of numerous clinical trials.

Dr Messina holds a Doctor of Philosophy from the Faculty of Medicine at the University of Sydney, and a Bachelor of Science (Honours) from the Department of Microbiology at the University of Sydney. She is also a Certified Medical Publication Professional and has been published extensively in a broad range of peer-reviewed publications.

Location

Sydney, Australia

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Race Oncology

Race Oncology (ASX: RAC) is a precision oncology company with a Phase II/III cancer drug called Bisantrene.


Industries

Headquarters

Sydney, Australia

Employees

1-10

Links